A detailed history of Resolute Financial, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Resolute Financial, LLC holds 6,070 shares of JNJ stock, worth $937,936. This represents 0.91% of its overall portfolio holdings.

Number of Shares
6,070
Previous 6,092 0.36%
Holding current value
$937,936
Previous $995,000 7.74%
% of portfolio
0.91%
Previous 0.94%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $3,524 - $3,955
-22 Reduced 0.36%
6,070 $1.07 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $79,213 - $88,144
-491 Reduced 7.46%
6,092 $995,000
Q2 2022

Aug 02, 2022

BUY
$168.19 - $186.01 $34,815 - $38,504
207 Added 3.25%
6,583 $1.17 Million
Q1 2022

Apr 15, 2022

BUY
$158.14 - $179.59 $1,106 - $1,257
7 Added 0.11%
6,376 $1.13 Million
Q4 2021

Feb 15, 2022

BUY
$155.93 - $173.01 $993,118 - $1.1 Million
6,369 New
6,369 $1.09 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Resolute Financial, LLC Portfolio

Follow Resolute Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Financial, LLC with notifications on news.